Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Emma Enrich"'
Autor:
Ana Marín-Sánchez, Daniel Álvarez-Sierra, Oscar González, Ana Lucas-Martin, Alicia Sellés-Sánchez, Francesc Rudilla, Emma Enrich, Roger Colobran, Ricardo Pujol-Borrell
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Graves' disease (GD) involves the presence of agonistic auto-antibodies against the thyrotropin receptor (TSHR), which are responsible for the clinical symptoms. While failure of TSHR tolerance is central to GD pathogenesis, the process leading to th
Externí odkaz:
https://doaj.org/article/12f757e9de684964b63eba553ec6460b
Autor:
Cortese, Maria Francesca, Palom, Adriana, Ruiz, Beatriz Pacín, Rudilla, Francesc, Randé, Emma Enrich, Iborra, Mireia Antón, Ruiz-Cobo, Juan Carlos, Barciela, Mar Riveiro, Tabernero, David, Rando-Segura, Ariadna, Herrero, Maria José, Buti, Maria
Publikováno v:
In Journal of Hepatology June 2024 80 Supplement 1:S741-S742
Autor:
Mar Sánchez, Francisco Vidal, Emma Enrich, Nina Borràs, Francesc Rudilla, Lluís Martorell, Irene Corrales, Eva Campos, Sergi Querol
Publikováno v:
Bone Marrow Transplantation. 55:1623-1631
Allele-level HLA compatibility in cord blood transplantation, together with noninherited maternal antigen or NIMA matching, have been associated with better transplant outcomes. The aim of this work is to develop a cost-efficient high-resolution HLA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a107df417ed78613aae166f53ea6e47
https://doi.org/10.1038/s41409-020-0890-9
https://doi.org/10.1038/s41409-020-0890-9
Autor:
Ana Castro, F. Sánchez-Gordo, Francesc Rudilla, Enric Carreras, Rafael F. Duarte, Isidro Prat, Sergio Querol, Antonio Balas, Francisco Vidal, Luisa Barea, Luis Larrea, Rafael Matesanz, Miguel Angel Pérez-Vaquero, Emma Enrich, Juan M. Gómez-Zumaquero, Gregorio Garrido
Publikováno v:
Bone Marrow Transplantation. 53:741-748
The possibility to use CCR5-∆32 umbilical cord blood to cure HIV infection in patients in need of a hematopoietic transplant has been suggested. The less stringent HLA compatibility needed in this type of transplant facilitates the search of a suit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c26626c51e6178fc8e001cb1c25f9d57
https://doi.org/10.1038/s41409-018-0114-8
https://doi.org/10.1038/s41409-018-0114-8
Autor:
Maria J. Herrero, Eva Campos, Francisco Vidal, Francesc Rudilla, Lluís Martorell, Emma Enrich, Sergi Querol
Publikováno v:
HLAREFERENCES. 94(4)
Allele-level HLA compatibility in cord blood transplantation has been associated with better transplant outcomes and is recommended as a selection criterion. It is also a crucial aspect for other therapeutic applications involving cord blood-derived
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e939f6face1adde1aa3420011696043
https://pubmed.ncbi.nlm.nih.gov/31353832
https://pubmed.ncbi.nlm.nih.gov/31353832
Autor:
Josep Lupón, Paloma Gastelurrutia, Eva Campos, Francesc Rudilla, Santiago Roura, Emma Enrich, Evelyn Santiago-Vacas, Sergi Querol, Antoni Bayes-Genis
Publikováno v:
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
ESC Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
ESC Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Allogeneic cell therapy; Haplotype frequency; Heart failure Teràpia cel·lular al·logènica; Freqüència haplotípica; Insuficiència cardíaca Terapia celular alogénica; Frecuencia haplotípica; Insuficiencia cardíaca AIMS: Cell therapy can be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1785f7eb96b9d005400bf93f4962fb6a
https://hdl.handle.net/11351/3819
https://hdl.handle.net/11351/3819
